Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Reynolds, DeWitt & Co. is a private investment firm headquartered in Cincinnati, Ohio, that specializes in venture capital, private equity, and leveraged buyouts. The firm has a significant historical footprint in the healthcare and life sciences sectors, most notably through its foundational and long-term investment in Meridian Bioscience, a global provider of diagnostic testing kits and life science raw materials. Founded by Mercer Reynolds and William DeWitt Jr., the firm provides strategic capital and management expertise to its portfolio companies to drive long-term growth. While the firm maintains a diversified portfolio, its principals have played instrumental roles in the governance and expansion of major healthcare entities. The firm typically operates as a private partnership, focusing on middle-market opportunities and strategic asset management.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Reynolds, Dewitt & Co..